Aiforia Technologies Plc
Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Trust70Data Trust: 70/100. Above median. Measured by StartupHub.ai. Median 61.Aiforia provides AI-powered image analysis solutions for pathology, assisting pathologists and scientists in preclinical and clinical labs.
About
Aiforia is a Helsinki-based life-science company that provides deep learning AI solutions for pathology. They offer software solutions that elevate diagnostic capabilities in image analysis, enabling medical discoveries. Their platform equips pathologists and scientists in preclinical and clinical labs with powerful deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses.
Similar companies
Digital pathology imaging technology and AI-driven precision pathology software.
Shares HealthTech, Biotechnology
AI-powered breast cancer detection and risk assessment solutions.
Shares HealthTech, Artificial Intelligence
Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.
Shares HealthTech, MedTech
Epitel develops AI-driven wireless brain health technologies for remote EEG monitoring, improving diagnosis and management of neurological conditions like epilepsy.
Shares HealthTech, Medical Devices
AI-powered medical imaging software for improved workflow and image quality.
Shares HealthTech, Artificial Intelligence
AI-powered platform for cancer diagnostics in digital pathology.
Shares Medical Imaging, Pathology
Public companies
Tempus AI acquired Paige, a digital pathology company that develops AI-assisted diagnostic and biomarker applications, directly competing with Aiforia's AI-powered image analysis solutions for pathology.
Competing product: Paige (acquired)
Roche is acquiring PathAI, a digital pathology firm specializing in AI-powered technology for pathology laboratories and the biopharma industry, which directly competes with Aiforia's offerings in AI-driven pathology image analysis.
Competing product: PathAI (acquired)
Danaher's operating company, Leica Biosystems, has a strategic investment and partnership with Indica Labs, a leader in AI-powered digital pathology software, creating a competing platform for AI-enabled cancer diagnostics.
Competing product: Leica Biosystems (with Indica Labs partnership)
Philips offers end-to-end digital pathology platforms that leverage AI and cloud-based solutions for remote collaboration and clinical standardization, directly competing with Aiforia's AI-powered image analysis for pathology.
Competing product: Philips Digital Pathology Solutions
Key facts
- Website
- aiforia.com
- Headquarters
- Helsinki, Finland
- Founded
- 2013
- Employees
- 4
- Total funding
- $22M (Debt)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 3 Aug 2026 | Debt | $22M | European Investment Bank (EIB) |
Tech stack
Detected on aiforia.com, last scanned 25 Oct 2026. Run your own scan
- Email provider
- Google Workspace, SendGrid
- Hiring platform
- Teamtailor
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Aiforia Technologies Plc trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Aiforia Technologies Plc is 70 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Aiforia Technologies Plc raised?
Aiforia Technologies Plc has raised a total of $22M in funding. The most recent round on record is Debt.
How many employees does Aiforia Technologies Plc have?
Aiforia Technologies Plc has approximately 4 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Aiforia Technologies Plc:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
